Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2. - Wikidata - awgldk - TriplyDB

Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.

Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.

http://www.wikidata.org/entity/Q34558230

about

A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.Live-attenuated bacteria as a cancer vaccine vector.Intracellular delivery of biologic therapeutics by bacterial secretion systems.The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents.Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads.

P2860

Q36883886-A1165CCF-4371-4A5C-A8DC-6730EE9B6D5E Q37502444-0F01C39E-6FEE-4036-A199-545936F767CB Q38152473-EEC296DD-8D29-479D-A5FF-DF3C5ADC3A2A Q38734240-F6AC9B53-4932-43D9-9F33-613FF1D2A7A0 Q44450039-29F8E37D-CAF3-4BFA-A6E9-069A433DD4C2 Q47399527-9D0DA546-6985-4B9B-9BA2-5F5A7984EF79

P2860

Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.

http://www.wikidata.org/entity/Q34558230

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Optimal epitope composition af ...... vector: application to TRP-2.

@ast

Optimal epitope composition af ...... vector: application to TRP-2.

@en

Optimal epitope composition af ...... vector: application to TRP-2.

@nl

type

label

Optimal epitope composition af ...... vector: application to TRP-2.

@ast

Optimal epitope composition af ...... vector: application to TRP-2.

@en

Optimal epitope composition af ...... vector: application to TRP-2.

@nl

prefLabel

Optimal epitope composition af ...... vector: application to TRP-2.

@ast

Optimal epitope composition af ...... vector: application to TRP-2.

@en

Optimal epitope composition af ...... vector: application to TRP-2.

@nl

P1433

Q34558230-6D4EDAE4-0D35-402D-A69E-9BFA4E74EE28

P1476

Q34558230-855B0526-7921-48A7-84E4-57657E5AD8B6

P2093

Q34558230-01203493-AB66-44D0-8274-F5950176EA19

Q34558230-1C2A3AE3-B9CF-4D2F-A9F9-26AF5D5116A8

Q34558230-3D52ADF8-D3BA-43E9-AC36-F9F5D97C1FE7

Q34558230-51C234C0-70E8-4B06-BB13-46E8461C4F57

Q34558230-7BBA5873-7430-4A53-9503-A032A6078C91

Q34558230-A62FB5F7-87E8-44DA-83AD-5EB0094B5F02

Q34558230-D1D04E3F-3FDE-453F-9339-B84E1FCCACD6

Q34558230-D2EFBB93-7944-41DB-B2A9-854CAF53B482

P2860

Q34558230-0A87A87D-0A26-4DE7-BC37-504D8787328C

Q34558230-102EE1C0-0794-4CB2-94DC-27936B9EC22C

Q34558230-10B76A53-20A2-4205-9AD6-113917E9C932

Q34558230-18F380BA-25B4-4A24-BCC8-FDC179A18013

Q34558230-19FCFB50-4BAF-413E-BC09-C36F94B0B703

Q34558230-26DE13FD-50BB-40BC-B1E6-A94643A99214

Q34558230-3D2D0EB1-FBD7-4CEB-AA10-52679B4B6ACC

Q34558230-426D32C5-1D22-4136-ABCC-4910FF630E23

Q34558230-4C08C74C-55B8-4FF5-B47D-659D44B5DEE0

Q34558230-4D80E613-ED33-49FB-862A-2AC4A3F921EF

P304

Q34558230-28438CDB-9792-422D-A24B-EF70308BCCB7

P31

Q34558230-FC6EE9F1-1CE9-4554-8D54-29A4F09E20FE

P356

Q34558230-A837A12F-A98B-40EA-9CD6-C43BD752A118

P433

Q34558230-BD1D3EE3-51FF-49FB-845D-D6CC3CFDC504

P478

Q34558230-61814EAB-EE97-4546-A0EF-3E6DC6FE03D2

P50

Q34558230-C0B05C98-EE41-4AED-823E-1BE1D7DF434E

P577

Q34558230-6C73D0DE-5B7A-4AD7-9D12-B9B8CE8B1365

P5875

Q34558230-88711D0E-3C82-400C-82C5-43BF5FFB7604

P698

Q34558230-BDD830B2-FA10-4884-B50D-0BAB0F71E534

P932

Q34558230-DEBDD08F-1313-4143-ACED-0BB7601D290F

P356

P1433

Bioengineered bugs

P1476

Optimal epitope composition af ...... y vector: application to TRP-2

@en

P2093

Audrey Le Gouellec

http://www.w3.org/2001/XMLSchema#string

Benoit Polack

http://www.w3.org/2001/XMLSchema#string

Bertrand Toussaint

http://www.w3.org/2001/XMLSchema#string

Jean-François Mayol

http://www.w3.org/2001/XMLSchema#string

Madiha Derouazi

http://www.w3.org/2001/XMLSchema#string

Nicolas Pasqual

http://www.w3.org/2001/XMLSchema#string

Olivier Epaulard

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Type III protein secretion systems in bacterial pathogens of animals and plants

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire

SYFPEITHI: database for MHC ligands and peptide motifs

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens.

Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa.

Orf1/SpcS chaperones ExoS for type three secretion by Pseudomonas aeruginosa.

BCG immunotherapy of bladder cancer: 20 years on.

Use of preferentially replicating bacteria for the treatment of cancer.

The type III secretion system tip complex and translocon.

P304

51-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/BBUG.1.1.9482

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49841749

http://www.w3.org/2001/XMLSchema#string

P698

21327126

http://www.w3.org/2001/XMLSchema#string

P932

3035149

http://www.w3.org/2001/XMLSchema#string